Pulmonx (LUNG) Stock Statistics & Valuation Metrics

Pulmonx has a market cap or net worth of $209.69M. The enterprise value is $223.49M.

Pulmonx has 40.25M shares outstanding. The number of shares has decreased by -2.65% in one year.

Pulmonx’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Pulmonx is -4.71. Pulmonx’s PEG ratio is 0.47.

In the last 12 months, Pulmonx had revenue of $83.79M and earned -$56.39M in profits. Earnings per share was -$1.44.

In the last 12 months, operating cash flow was -$31.54M and capital expenditures -$1.45M, giving a free cash flow of -$32.98M billion.

Pulmonx pays an annual dividend of , resulting in a dividend yield of

Pulmonx upcoming earnings date is May 6, 2025, After Close.

Pulmonx as a current ratio of 5.58, with Debt / Equity ratio of 0.66

In the past 12 months, Pulmonx has paid $500.00K in taxes.

Pulmonx EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Pulmonx has $101.48M in cash and marketable securities with $56.47M in debt, giving a net cash position of -$45.01M billion.

Gross margin is 74.00%, with operating margin of -68.87%, and net profit margin of -67.30%.

The average price target for Pulmonx is $13.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy